<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Congenital long QT syndrome: Diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Congenital long QT syndrome: Diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Congenital long QT syndrome: Diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Schwartz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael J Ackerman, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John K Triedman, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Samuel Asirvatham, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 13, 2019.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Long QT syndrome (LQTS) is a disorder of ventricular myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG)  (<a class="graphic graphic_waveform graphicRef77018" href="/z/d/graphic/77018.html" rel="external">waveform 1</a>) that can lead to symptomatic ventricular arrhythmias and an increased risk of sudden cardiac death (SCD) [<a href="#rid1">1</a>]. The primary symptoms in patients with LQTS include syncope, seizures, cardiac arrest, and SCD. LQTS is associated with an increased risk of a characteristic life-threatening cardiac arrhythmia known as torsades de pointes or "twisting of the points"  (<a class="graphic graphic_waveform graphicRef73827" href="/z/d/graphic/73827.html" rel="external">waveform 2</a>) [<a href="#rid2">2</a>].</p><p>LQTS may be congenital or acquired [<a href="#rid1">1,3-7</a>]. Pathogenic variants in up to 17 genes have been identified thus far in patients with congenital LQTS; the three major genetic subtypes are designated LQT1 through LQT3 while the minor LQTS-susceptibility genes are designated by their genetic substrate (eg, CALM1-LQTS)  (<a class="graphic graphic_table graphicRef114927" href="/z/d/graphic/114927.html" rel="external">table 1</a>) [<a href="#rid7">7</a>]. Acquired LQTS usually results from undesired QT prolongation and potential for QT-triggered arrhythmias by either QT-prolonging disease states, QT-prolonging medications (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.crediblemeds.org%2F&amp;token=F2fTJXWTbAdqtiUVhUGfEeHvm%2Bapw8j0DIpr7ZimhTcQDLZbSKKNNIJ4B%2FwprPZ%2F&amp;TOPIC_ID=1053" target="_blank">www.crediblemeds.org</a>), or QT-prolonging electrolyte disturbances  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">"Congenital long QT syndrome: Pathophysiology and genetics"</a>.)</p><p>The ECG features and diagnostic approach to persons with suspected congenital LQTS will be reviewed here [<a href="#rid1">1</a>]. The epidemiology, clinical features, and management of congenital LQTS in children and adults and the acquired LQTS are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/988.html" rel="external">"Congenital long QT syndrome: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">"Acquired long QT syndrome: Definitions, pathophysiology, and causes"</a> and  <a class="medical medical_review" href="/z/d/html/116011.html" rel="external">"Acquired long QT syndrome: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H3618925434"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H2364630001"><span class="h2">Our approach</span><span class="headingEndMark"> — </span>Our approach to evaluating the patient with suspected congenital LQTS involves multiple steps [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For all patients, the initial evaluation of suspected congenital LQTS should include obtaining a comprehensive personal and family history, performance of a physical examination, and review of an ECG (examination of serial ECGs is extremely helpful). The ECGs are examined to determine both the length of repolarization (the QTc) and the look of repolarization (T wave morphology).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When available, ECGs are also obtained from immediate family members to determine if any first-degree relatives (parents, siblings, and/or children) exhibit QT prolongation or other associated abnormalities.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary causes of QT prolongation and the acquired LQTS should be excluded  (<a class="graphic graphic_table graphicRef57431" href="/z/d/graphic/57431.html" rel="external">table 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Besides the resting ECG, 24-hour ambulatory ECG monitoring (full 12-lead monitoring, if available) is performed as well, looking for arrhythmias as well as any dynamic T wave changes including (rarely) macroscopic T wave alternans, especially at nighttime.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the patient is old enough and able to perform a bicycle or treadmill stress test, we perform an exercise stress test looking for exercise-associated arrhythmias, changes in T wave morphology, and the presence of a maladaptive QT response during the recovery phase. A QTc &gt;470 milliseconds at two through five minutes of recovery is highly suggestive of LQT1. (See <a class="local">'Exercise testing'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calculation of the LQTS diagnostic score, also known as the "Schwartz Score." (See <a class="local">'Diagnosis'</a> below.)</p><p></p><p class="headingAnchor" id="H4198861924"><span class="h2">Clinical and family history</span><span class="headingEndMark"> — </span>Obtaining a detailed personal medical history and a multi-generation family history is crucial in determining the pretest likelihood of congenital LQTS. The personal clinical history should focus on signs and symptoms suggestive of tachyarrhythmia, particularly ventricular tachyarrhythmias, as many LQTS families have pre-sudden death warning signs including:</p><p class="bulletIndent1"><span class="glyph">●</span>Syncope suggestive of cardiac/arrhythmic origin (ie, not vasovagal syncope)</p><p class="bulletIndent1"><span class="glyph">●</span>Syncope followed by generalized seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Resuscitated sudden cardiac arrest</p><p></p><p>Additionally, obtaining a multi-generation family history, and utilizing a genetic counsellor when available, is also crucial to establishing the clinical likelihood of congenital LQTS. Key family history items that increase the likelihood of congenital LQTS include:</p><p class="bulletIndent1"><span class="glyph">●</span>Premature sudden deaths (&lt;40 years of age and autopsy negative)</p><p class="bulletIndent1"><span class="glyph">●</span>Unexplained motor vehicle accidents</p><p class="bulletIndent1"><span class="glyph">●</span>Unexplained drownings</p><p class="bulletIndent1"><span class="glyph">●</span>Generalized seizures (frequently, patients with LQTS have been misdiagnosed with, and treated for, epilepsy)</p><p></p><p>After obtaining the clinical and family history and reviewing the results of the resting, ambulatory, and stress ECGs, the LQTS diagnostic score can be calculated. (See <a class="local">'12-lead ECG'</a> below and <a class="local">'Ambulatory ECG monitoring'</a> below and <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H2"><span class="h2">12-lead ECG</span><span class="headingEndMark"> — </span>All patients being evaluated for congenital LQTS should have multiple 12-lead ECGs performed. The QT interval should be measured manually on serial ECGs using multiple leads (preferably leads II and V5) and then corrected for heart rate. Once consistent QTc prolongation has been shown on two ECGs (on occasion even one ECG is sufficient), serial ECG testing may be discontinued altogether or at least the interval of surveillance lengthened. The point at which serial ECG testing can be discontinued is highly variable, depending upon the patient’s age, growth patterns, and the significance of previous ECG findings. Even after the diagnosis of LQTS is established, most pediatric patients with LQTS will have a 12-lead ECG and 12-lead ambulatory ECG monitoring performed every one to two years. In Europe there is a preference for yearly (rather than every two years) follow-up, including an exercise stress test. If low-risk and asymptomatic, most adults with LQTS will continue to have periodic cardiac re-evaluations every one to five years. Sometimes, the ECG itself is used to monitor satisfaction with the LQTS-directed treatment program such as when <a class="drug drug_general" data-topicid="9648" href="/z/d/drug information/9648.html" rel="external">mexiletine</a> is used to attenuate the QTc. If so, a follow-up ECG may be obtained even more frequently than annually. While yearly ECGs in general are most appropriate, obtaining an ECG more frequently (eg, every one to two months) is usually unnecessary and unacceptable.</p><p>In addition, beat-to-beat variability and respiratory sinus arrhythmia affect formulas used to correct for heart rate. As a result, several successive beats may on occasion need to be measured and averaged for each ECG. (See <a class="local">'QT rate correction'</a> below and <a class="local">'Special circumstances'</a> below.)</p><p>Prolongation of the QTc is an essential component of the diagnosis of LQTS. However, the QTc varies in response to a number of factors, such as autonomic state, electrolyte imbalance, drugs, and diurnal changes [<a href="#rid8">8,9</a>].</p><p>Other ECG features, such as T wave morphology and bradycardia, may be useful in the evaluation of the patient with suspected LQTS, but the QTc appears to be the most useful diagnostic and prognostic parameter [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H3"><span class="h3">General ECG principles</span><span class="headingEndMark"> — </span>The QT interval reflects the time required for both depolarization (the QRS complex) and repolarization (the T wave) of the ventricles. Repolarization is a larger component of the entire QT interval, and QT prolongation is generally considered to reflect abnormalities of repolarization.</p><p>The QT interval varies inversely with the heart rate; therefore, the QT measurement is adjusted for the heart rate, resulting in the corrected QT interval, or QTc. (See <a class="local">'QT rate correction'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Measuring the QT interval</strong> – The computer-derived QTc should always be confirmed or corrected manually. The QT interval is measured from the onset of the QRS complex to the point at which the T wave ends  (<a class="graphic graphic_waveform graphicRef77018" href="/z/d/graphic/77018.html" rel="external">waveform 1</a>). Accurate measurements can be technically challenging, largely due to difficulties in determining the precise termination of the T wave. The QT interval should be measured in different beats and in several leads. The technique of measuring the QT interval is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2121.html" rel="external">"ECG tutorial: ST and T wave changes", section on 'Prolonged QT interval'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of U waves</strong> – Identifying the termination of the T wave can be particularly difficult when a U wave is present. The U wave should not be included if it is distinct from and smaller than the T wave (generally excluded if the T wave has returned completely to the isoelectric line and then a U wave that is &lt;one-half the amplitude of the preceding T wave is inscribed). Erroneous inclusion of the U wave in the QT interval measurement can lead to overdiagnosis of LQTS [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Which lead should be used?</strong> – QT intervals vary significantly among leads [<a href="#rid12">12</a>]. Most normal reference ranges are based upon measurements from lead II, and lead V5 is often favored because of the clarity of T wave termination [<a href="#rid13">13,14</a>]. Additionally, some experts find leads V2 and V3 to be very useful, since QT measurements are typically the longest in these leads [<a href="#rid12">12,14</a>]. Other experts, however, avoid measuring the QT interval in leads V2 and V3, particularly in adolescents and children in whom a U wave is frequently present, making it more difficult to precisely determine the point of T wave termination.</p><p></p><p class="headingAnchor" id="H3406673"><span class="h3">QT rate correction</span><span class="headingEndMark"> — </span>Under normal circumstances, the duration of repolarization depends upon the heart rate. The QT interval is longer at slower rates and shorter at faster rates. For this reason, formulas have been developed to "correct" the QT interval for heart rate (or the duration of the RR interval), although none is ideal (<a class="calc calc_professional" href="/z/d/html/13459.html" rel="external">calculator 1</a>) [<a href="#rid8">8,15-17</a>]. The most commonly used rate correction formula was developed by Bazett [<a href="#rid18">18</a>]:</p><div class="formulaContainer"><div class="formula"><p>  QTc = QT interval ÷ √RR interval (in sec)</p></div></div><p>Although this approach is simple and generally accurate, it is less accurate at heart rate extremes and results in overcorrecting at high heart rates and undercorrecting at low heart rates [<a href="#rid8">8</a>]. Normative values are available for newborns and older children, which are standardized by age [<a href="#rid19">19-21</a>].</p><p class="headingAnchor" id="H4256375483"><span class="h3">Normal QTc ranges</span><span class="headingEndMark"> — </span>Overall, the average QTc in healthy persons after puberty is 420±20 milliseconds, while during infancy the average QTc is 400±20 milliseconds. By contrast, the average QTc among patients with genetically confirmed LQTS is approximately 470 milliseconds, although patients with confirmed LQTS can exhibit a wide range of QTc values (360 to &gt;800 milliseconds in our experts practices).</p><p>In general, the 99th percentile QTc values are 460 milliseconds (prepuberty), 470 milliseconds in postpubertal males, and 480 milliseconds in postpubertal females. Asymptomatic patients who incidentally exceed these values on serial ECGs, and do not have any acquired QT-prolonging factors, should be evaluated further for the possibility of congenital LQTS as they now have a 10 percent chance of having LQTS (rather than the 1 in 2000 chance that they had prior to getting an ECG). </p><p>Further, for asymptomatic children with an otherwise idiopathic QTc &gt;480 milliseconds and asymptomatic adults with an otherwise idiopathic QTc &gt;500 milliseconds, LQTS genetic testing is recommended since at these thresholds, LQTS is now more likely for that patient than merely being an extreme QTc outlier. Further, patients with a QTc &gt;500 milliseconds are at increased risk of SCD. (See <a class="local">'Genetic testing'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h3">Special circumstances</span><span class="headingEndMark"> — </span>In addition to the methodologic and technical challenges discussed above, QT measurement and interpretation is complicated in the following situations:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atrial fibrillation (AF)</strong> – Due to the irregular changes in the RR interval, the QT interval can vary on a beat-to-beat basis during AF. To accommodate this variability, some clinicians recommend averaging the measurements over 10 beats. Others advise measuring the QT intervals that follow the longest and shortest RR intervals in the ECG, then dividing each by the square root of the preceding RR interval [<a href="#rid15">15</a>]. The average of these two values is then used as the corrected QT interval. Still others find the measurement of QT and QTc in AF to be completely unreliable and instead focus on the look of repolarization (T wave morphology characteristics) rather than trying to measure the length of repolarization in AF.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sinus arrhythmia</strong> – Similarly, in cases with marked RR variability, the QT rate correction formulas may not be as accurate, and taking an average of multiple beats can reduce the variation due to respiratory sinus arrhythmia. Another approach in such patients is to attempt to identify beats which are further away from any longer pauses and measure the QT in those beats.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>QRS prolongation</strong> – QT prolongation usually reflects abnormal repolarization, but when depolarization (the QRS complex) is abnormal and prolonged, the significance of mild QT prolongation is uncertain. It has been suggested that measurement of the JT interval (defined as the QT interval minus the QRS duration) may be a more appropriate way to identify abnormalities in repolarization in such patients [<a href="#rid22">22</a>]. The normal JTc is less than 360 milliseconds in children without LQTS and is typically greater than 360 milliseconds in children with LQTS [<a href="#rid22">22</a>]. However, the validity of using the JT interval in this manner has been questioned. An alternative approach is to adjust the QT interval as a linear function to account for QRS duration and heart rate in the setting of ventricular conduction delay [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1">Another approach is to use a threshold of 500 milliseconds for a prolonged QTc in the setting of a wide QRS complex [<a href="#rid15">15</a>]. However, this threshold will result in an overdiagnosis of LQTS. Importantly, patients with congenital LQTS almost never have concomitantly prolonged QRS values. Recalling JT interval norms is also problematic. Instead, a simple wide QRS adjustment formula can be used:</p><p></p><p class="bulletIndent1">Wide QRS adjusted QTc = QTc – [QRS – 100]</p><p></p><p class="headingAnchor" id="H11"><span class="h3">Other ECG features</span><span class="headingEndMark"> — </span>The T waves of patients with congenital LQTS are frequently abnormal with a biphasic contour or a prominent notched component (particularly in LQT2). However, this finding is fairly insensitive, and the absence of an abnormal T wave morphology does not exclude patients from having congenital LQTS. In one report, notched or biphasic T waves were present in 62 percent of patients with LQTS compared with 15 percent of control subjects [<a href="#rid24">24</a>]. A variety of other atypical T wave shapes have also been described in LQTS [<a href="#rid25">25</a>]. In experienced hands, T wave morphology, when coupled with knowledge about arrhythmia triggers, may suggest a particular genotype (such as notched T waves plus auditory triggers during the postpartum period equating with LQT2), but the presence or absence of T wave abnormalities does not alter the diagnostic evaluation in any notable way.</p><p class="headingAnchor" id="H2422904898"><span class="h2">Exercise testing</span><span class="headingEndMark"> — </span>In nearly all patients (ie, those who are old enough to cooperate and are capable of performing an exercise protocol) with known or suspected congenital LQTS, we perform an exercise (treadmill or bicycle) ECG stress test as part of the initial diagnostic evaluation. Additionally, for patients diagnosed with congenital LQTS, we repeat an exercise ECG stress test every one to five years (annually for previously symptomatic patients, less frequently for asymptomatic, low-risk adults) as part of the ongoing follow-up. The response to ECG testing in patients with suspected congenital LQTS is frequently subtle and complex, requiring a high degree of aptitude to correctly interpret and diagnose the findings. If doubt exists surrounding the interpretation or implication of ECG findings post-exercise, the patient should be referred to a clinician with specific expertise and experience with congenital LQTS.</p><p>ECG stress testing in patients with suspected congenital LQTS is performed to assess for exercise-associated arrhythmias, changes in T wave morphology, and the presence of a maladaptive QT response during the recovery phase. Physiologically, the QT interval shortens with exercise and with increased heart rate. By contrast, in individuals with LQT1, the QT interval may fail to shorten or may lengthen with exertion and at higher heart rates, and may be prolonged during the recovery phase after exercise.</p><p>At least part of the variability in the response to exercise in LQTS patients results from different responses among the major types of congenital LQTS:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with LQT1 have diminished shortening of the QT interval and a reduced chronotropic response during exercise followed by exaggerated lengthening of the QT interval as the heart rate declines during early and late (eg, one and four minutes) recovery after exercise [<a href="#rid26">26-28</a>]. This is due to the fact that their pathogenic variants impair the function of the Kv7.1 outward-rectifying potassium channels, which contributes to shortening the action potential during activation of the sympathetic nervous system.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many patients with LQT2 have marked QT interval shortening and a normal chronotropic response during exercise, although there are exceptions [<a href="#rid26">26,29</a>]. There is exaggerated lengthening of the QT interval as the heart rate declines during late recovery (eg, &gt; four minutes) after exercise [<a href="#rid26">26,28</a>].</p><p></p><p>These characteristics may explain the observation that many cardiac events occur during exercise in LQT1  (<a class="graphic graphic_figure graphicRef64239" href="/z/d/graphic/64239.html" rel="external">figure 1</a>) [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations", section on 'Triggers of arrhythmia'</a>.)</p><p>Accentuated heart rate recovery following standard exercise testing, a marker of vagal activity, appears to be a marker of increased risk of cardiac events (syncope or aborted SCD) in patients with LQT1. Among 169 patients identified as LQT1 genotype positive who underwent standard exercise testing and achieved similar maximal heart rate and workloads, those with prior cardiac events had a significantly greater heart rate recovery during the first minute following exercise compared with those without prior events (19 versus 13 beats per minute in a 47 patient South African cohort; 27 versus 20 beats per minute in a 122 patient Italian cohort) [<a href="#rid31">31</a>]. Greater heart rate reductions immediately following exercise in persons positive for the LQT1 genotype appear to risk stratify them at a higher risk of arrhythmic events.</p><p>The response of QTc during exercise recovery may be helpful in identifying LQTS in asymptomatic relatives of individuals with LQTS as well as in identifying probands [<a href="#rid28">28</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Supine QTc at rest:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If ≥470 milliseconds in males or ≥480 milliseconds in females with personal or family history suspicious for LQTS, then the patient has high probability LQTS (estimated at &gt;90 percent likelihood). However, if the patient exceeds these QTc thresholds but is &lt;500 milliseconds AND has no personal or family history to suggest LQTS, then although the patient is graded as intermediate probability LQTS by the Schwartz score, this should not be viewed as definite LQTS. Instead, the patient has a small but definite chance (5 to 20 percent) of having congenital LQTS.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If normal or borderline normal – Check the QTc during the recovery phase of the stress test.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recovery QTc at two, three, or four minutes into recovery after peak exercise:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If QTc ≥470 milliseconds, then there is an estimated 70 percent positive predictive value (PPV) for unmasking LQT1 [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the QTc at five minutes of recovery is ≥470 milliseconds and is 40 to 50 milliseconds greater than the QTc at one minute of recovery (ie, QTc latency), then LQT2 is possible (approximately 70 percent PPV).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The QTc values shorten during exercise and in recovery in patients with LQT3, and therefore stress testing is not helpful in LQT3. However, if the patient exhibits QT prolongation at rest and then the QTc shortens at peak exercise and in recovery, then LQT3 emerges as the possible underlying genotype.</p><p></p><p>In addition, the stress test is often used to assess the adequacy of beta blockade by noting a measurable reduction in maximum heart rate. However, there is no particular threshold of peak heart rate reduction (ie, 20, 25, 30 percent, etc) that guarantees protection from ventricular arrhythmias and SCD. Instead, this assessment at least confirms that reasonable levels of beta blocker have been achieved in the patient. </p><p class="headingAnchor" id="H20"><span class="h2">Ambulatory ECG monitoring</span><span class="headingEndMark"> — </span>In patients with known or suspected congenital LQTS, we perform ambulatory ECG monitoring to help establish the diagnosis of LQTS and to add corroborative information in borderline cases [<a href="#rid33">33-36</a>]. The QT interval and other ECG features of LQTS may vary with activity and time of day. Holter monitoring can detect intermittent QT prolongation, bradyarrhythmia, macroscopic T wave alternans, and T wave notching [<a href="#rid33">33,35,36</a>]. A 12-lead ambulatory ECG monitor can be helpful to detect abnormal changes in T wave morphology, especially at night.</p><p>The results of ambulatory monitoring should be interpreted with caution, however, since patients without congenital LQTS can have QT intervals over the normal limits at times, reducing the specificity of Holter monitor QTc results [<a href="#rid37">37</a>]. However, this usually happens with rapid heart rate increases, and the expert observer is not misled. Discrepancies in measurements may occur when Holter recordings are compared with standard ECGs.</p><p>Given the limitations of Holter monitoring for establishing the diagnosis of LQTS, we do not recommend making the diagnosis of LQTS based solely on the QTc measurement during ambulatory recordings. The results of such testing should be used only as ancillary information.</p><p class="headingAnchor" id="H1809435052"><span class="h2">Provocative testing</span><span class="headingEndMark"> — </span>In some patients, the diagnosis of congenital LQTS may be uncertain after application of the diagnostic criteria outlined above. Additional testing, including serial cardiologic testing of the index case and appropriate relatives and provocative electrocardiographic testing with catecholamines (the <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> QT stress test), facial immersion, abrupt supine-to-standing ECG, or mental stress test [<a href="#rid38">38</a>], may be helpful in such patients. However, these tests must be interpreted with great caution as the positive predictive values are generally 70 percent or less.</p><p class="headingAnchor" id="H24"><span class="h2">Genetic testing</span><span class="headingEndMark"> — </span>Our recommendations for genetic testing in the evaluation of suspected congenital LQTS are generally in accord with those of professional societies [<a href="#rid39">39-41</a>]. We proceed with genetic testing in the following instances:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a high clinical suspicion of congenital LQTS based on history, family history, ECG findings, and results of any additional testing, such as a high Schwartz score ≥3.5 (Class I recommendation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with an intermediate clinical suspicion of congenital LQTS based on history, family history, ECG findings, and results of any additional testing, such as an intermediate Schwartz score of 1.5 to 3 (Class II recommendation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic patients without a family history of congenital LQTS but who have serial ECGs with QTc ≥480 milliseconds before puberty or ≥500 milliseconds post-puberty (Class I recommendation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic patients without a family history of congenital LQTS but who have serial ECGs with QTc ≥460 milliseconds before puberty or ≥480 milliseconds post-puberty (Class II recommendation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cascade/variant-specific testing of all appropriate relatives when the disease-causative variant has been identified in the proband (Class I recommendation).</p><p></p><p class="bulletIndent1">This generally proceeds in concentric circles of relatedness. For example, if the LQTS-causative variant was inherited paternally, then the paternal aunts and uncles are tested first rather than testing them and the cousins at the same time. If an aunt, for example, tests negative, then there is generally no need to perform cascade testing on that aunt's children. Among families with genetically proven/confirmed LQTS, it is unacceptable to tell family members/relatives that they do or do not have LQTS based solely on their ECG. Only a negative variant-specific genetic test result <strong>and</strong> a normal ECG in that relative can prompt the conclusion that the relative does <strong>not</strong> have LQTS and can be dismissed from follow-up.</p><p></p><p>Genetic testing will identify a specific LQTS-causative variant in approximately 80 percent of patients with a high probability LQTS diagnosis (ie, Schwartz score &gt;3.5). It may establish the diagnosis when it is uncertain, allow for efficient identification of affected family members, and have prognostic and therapeutic utility by determining which gene is involved. (See  <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">"Congenital long QT syndrome: Pathophysiology and genetics"</a>.)</p><p>Genetic testing to identify the patient's LQTS-causative variant is now more readily available for clinical use [<a href="#rid4">4,7,42-44</a>].<strong> </strong>As a result, genotyping has become more frequently utilized as part of the diagnostic and prognostic evaluation of patients with congenital LQTS. However, congenital LQTS is a complex and genetically heterogeneous condition, so a negative test does not exclude disease. Nevertheless, when a negative genetic test is obtained (which by itself rules out approximately 80 percent of congenital LQTS), it is very reasonable to reassess the veracity of the clinical diagnosis of congenital LQTS. If the diagnosis is robust, then the patient belongs to the 20 percent subset of genotype negative congenital LQTS patients, and the patient and their family should be connected to research laboratories to search for their genetic cause of LQTS. On the other hand, if the strength of the evidence was weak/inconclusive in the first place, then a negative genetic test can help begin the subsequent reevaluation efforts to move away from and rescind the previously rendered diagnosis of congenital LQTS, which can involve the removal of previously implanted defibrillators as well [<a href="#rid45">45,46</a>].<strong> </strong>This is yet another reason why consideration for referral to LQTS specialty centers should be given. In one dedicated LQTS clinic, 40 percent of the patients who came with the diagnosis of LQTS were dismissed without the diagnosis of LQTS, with the vast majority of those being reclassified as otherwise healthy without any evidence of important heart disease [<a href="#rid45">45</a>].</p><p>Genetic testing in LQTS is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">"Congenital long QT syndrome: Pathophysiology and genetics"</a>.)</p><p class="headingAnchor" id="H3346885055"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>For all patients in whom congenital LQTS is suspected following the initial evaluation, we calculate the Schwartz score to better estimate the clinical likelihood of a congenital LQTS diagnosis and proceed directly to phenotype-directed genetic testing (ie, the genetic test panel that comprises the established LQTS-susceptibility genes)  (<a class="graphic graphic_table graphicRef113828" href="/z/d/graphic/113828.html" rel="external">table 3</a>).</p><p>A weighted, non-genetic scoring system for the diagnosis of congenital LQTS, also called the "Schwartz score," incorporates the measured QTc and other clinical and historical factors; the score was developed in 1985 [<a href="#rid47">47</a>] and revised in 1993 [<a href="#rid48">48</a>], 2006 [<a href="#rid49">49</a>], and 2011 [<a href="#rid50">50</a>]. An algorithm was developed in which diagnostic criteria were assigned points as follows  (<a class="graphic graphic_table graphicRef113828" href="/z/d/graphic/113828.html" rel="external">table 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG findings</strong> (in the absence of medications or disorders known to affect these features):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>QTc (= QT/√RR, interpret with caution with tachycardia since QTc overcorrects at fast heart rates)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>≥480 milliseconds: 3 points</p><p class="bulletIndent3"><span class="glyph">-</span>460 to 479 milliseconds: 2 points</p><p class="bulletIndent3"><span class="glyph">-</span>450 to 459 milliseconds (in males): 1 point</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>QTc at fourth minute of recovery from exercise stress test ≥480 milliseconds: 1 point [<a href="#rid50">50</a>] (see <a class="local">'Exercise testing'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Torsades de pointes* (in the absence of drugs known to prolong QT): 2 points</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>T wave alternans: 1 point</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Notched T wave in three leads: 1 point</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Resting heart rate below second percentile for age (restricted to children): 0.5 point</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Syncope* (*Points for documented torsade and syncope are mutually exclusive)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>With stress: 2 points</p><p class="bulletIndent3"><span class="glyph">-</span>Without stress: 1 point</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> (the same family member cannot be counted in both of these criteria):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Family members with LQTS: 1 point</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained SCD in immediate family members &lt;30 years of age: 0.5 point</p><p></p><p>The points are added to calculate the LQTS diagnostic score ("Schwartz Score"). The 2006 and 2011 versions rate the probability of having LQTS according to the number of accrued points [<a href="#rid49">49,50</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low</strong> – ≤1 point</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intermediate</strong> – 1.5 to 3 points</p><p class="bulletIndent1"><span class="glyph">●</span><strong>High</strong> – ≥3.5 points</p><p></p><p>When a patient satisfies a high probability Schwartz score (ie, ≥3.5 points), the likelihood of a positive LQTS genetic test is approximately 80 percent. While an intermediate probability Schwartz score warrants further pursuit of the possibility of congenital LQTS (ie, genetic testing of the patient and ECG testing of his/her relatives), it does not equal a diagnosis of congenital LQTS. In this setting, the likelihood of LQTS is approximately a 5 to 20 percent chance, far higher than the 1 in 2000 background rate for this disease. In such a patient, when genetic testing is pursued, and if it comes back negative (thereby ruling out 80 percent of LQTS by itself), such a patient with an "intermediate probability" Schwartz score could be dismissed as normal eventually with insufficient evidence to merit the diagnosis of LQTS. Importantly, if the Schwartz score is low (&lt;1 point), genetic testing should <strong>not</strong> be pursued. Do not label such individuals as borderline LQTS or possible LQTS. Instead, in most circumstances, these patients should be reclassified quickly as normal and dismissed from follow-up.  </p><p class="headingAnchor" id="H4272796215"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/116416.html" rel="external">"Society guideline links: Inherited arrhythmia syndromes"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/115586.html" rel="external">"Society guideline links: Ventricular arrhythmias"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112356.html" rel="external">"Society guideline links: Cardiac implantable electronic devices"</a>.)</p><p class="headingAnchor" id="H1757172562"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/86973.html" rel="external">"Patient education: Long QT syndrome (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H41937607"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Long QT syndrome (LQTS) is a disorder of ventricular myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG)  (<a class="graphic graphic_waveform graphicRef77018" href="/z/d/graphic/77018.html" rel="external">waveform 1</a>), ventricular arrhythmias, and an increased risk of sudden cardiac death (SCD) caused by torsades de pointes or "twisting of the points"  (<a class="graphic graphic_waveform graphicRef73827" href="/z/d/graphic/73827.html" rel="external">waveform 2</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LQTS may be congenital or acquired. Pathogenic variants in up to 17 genes have been identified thus far in patients with genetic LQTS; the major and most important genetic subtypes are designated LQT1 through LQT3, while the minor LQTS-susceptibility genes are designated by their genetic substrate such as CALM1-LQTS, for example  (<a class="graphic graphic_table graphicRef114927" href="/z/d/graphic/114927.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The initial diagnostic strategy includes evaluation of the presenting event (eg, syncope, seizures, sudden cardiac arrest, or SCD), obtaining a careful family history, careful evaluation of the QTc, exclusion of secondary causes of QT prolongation, ambulatory ECG monitoring (with 12-lead ECG if at all possible), exercise testing, and calculation of the LQTS diagnostic score (the "Schwartz score"). (See <a class="local">'Our approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obtaining a detailed personal medical history and multi-generation family history is crucial in determining the pretest likelihood of congenital LQTS. The personal clinical history should focus on signs and symptoms suggestive of tachyarrhythmia, particularly ventricular tachyarrhythmias, as many LQTS families have pre-sudden death warning signs including syncope suggestive of cardiac etiology, syncope followed by generalized seizures, or resuscitated sudden cardiac arrest. (See <a class="local">'Clinical and family history'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All patients being evaluated for congenital LQTS should have a 12-lead ECG performed. The QT interval should be measured manually on serial ECGs using multiple leads (preferably leads II and V5), and then corrected for heart rate. The heart rate corrected QT interval (QTc) is the most useful diagnostic and prognostic parameter for LQTS. The computer-derived QTc should always be confirmed or corrected manually. Since the QTc varies in response to physiologic factors and drugs, the sensitivity of a QTc from a single ECG is less than 100 percent, and serial ECG testing is required frequently. (See <a class="local">'12-lead ECG'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The average QTc values in healthy adults are 420±20 milliseconds with 99th percentile values being 460 milliseconds (prepuberty), 470 milliseconds (postpubertal males), and 480 milliseconds (postpubertal females). (See <a class="local">'Normal QTc ranges'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other ECG features of LQTS include abnormal T wave morphology, T wave alternans, and increased QT dispersion. (See <a class="local">'Other ECG features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In nearly all patients (ie, those who are old enough to cooperate and are capable of performing an exercise protocol) with known or suspected congenital LQTS, we perform an exercise (treadmill or bicycle) ECG stress test as part of the initial diagnostic evaluation to assess for exercise-associated arrhythmias, changes in T wave morphology, and the presence of maladaptive QT response during the recovery phase. (See <a class="local">'Exercise testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with known or suspected congenital LQTS, we perform ambulatory ECG monitoring (with 12-lead ECG if available) to help establish the diagnosis of LQTS and to add corroborative information in borderline cases. (See <a class="local">'Ambulatory ECG monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The LQTS diagnostic score ("Schwartz score") may be helpful in evaluating individuals with suspected LQTS but is not adequate for screening of family members of affected individuals. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic testing will identify a specific LQTS-causative variant in approximately 80 percent of patients with a definite diagnosis of LQTS. Genetic testing should be viewed as standard of care in the diagnostic and prognostic evaluation of LQTS on par with the ECG itself. It may establish the diagnosis when it is uncertain, allow for efficient identification of affected family members, and have prognostic and therapeutic utility by determining which gene is involved. By all major cardiac societies throughout the world, genetic testing is indicated clinically for any patient in whom the diagnosis of LQTS is being considered or for whom the diagnosis of LQTS has been established already. (See <a class="local">'Genetic testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among families with genetically proven/confirmed LQTS, it is unacceptable to tell family members/relatives that they do or do not have LQTS based solely on their ECG. Only a negative variant-specific genetic test result <strong>and</strong> a normal ECG in that relative can prompt the conclusion that the relative does <strong>not</strong> have LQTS and can be dismissed from follow-up. (See <a class="local">'Genetic testing'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 2013; 34:3109.</a></li><li><a class="nounderline abstract_t">Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013.</a></li><li><a class="nounderline abstract_t">Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 2002; 112:58.</a></li><li><a class="nounderline abstract_t">Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.</a></li><li><a class="nounderline abstract_t">Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J 2000; 21:1232.</a></li><li><a class="nounderline abstract_t">Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000; 36:1.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AAM. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013; 62:169.</a></li><li><a class="nounderline abstract_t">Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993; 72:17B.</a></li><li><a class="nounderline abstract_t">Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2001; 12:411.</a></li><li><a class="nounderline abstract_t">Mönnig G, Eckardt L, Wedekind H, et al. Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J 2006; 27:2074.</a></li><li><a class="nounderline abstract_t">Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007; 115:2613.</a></li><li><a class="nounderline abstract_t">Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988; 61:83.</a></li><li class="breakAll">Goldman MJ. Principles of Clinical Electrocardiography, 8th ed, Lange Medical Pub, Los Altos 1973.</li><li><a class="nounderline abstract_t">LEPESCHKIN E, SURAWICZ B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952; 6:378.</a></li><li><a class="nounderline abstract_t">Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003; 289:2120.</a></li><li><a class="nounderline abstract_t">Toivonen L. More light on QT interval measurement. Heart 2002; 87:193.</a></li><li><a class="nounderline abstract_t">Hnatkova K, Malik M. "Optimum" formulae for heart rate correction of the QT interval. Pacing Clin Electrophysiol 1999; 22:1683.</a></li><li><a class="nounderline abstract_t">Bazett, HC . An analysis of the time-relations of electrocardiograms. Heart 1920; 7:353.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Garson A Jr, Paul T, et al. Guidelines for the interpretation of the neonatal electrocardiogram. A task force of the European Society of Cardiology. Eur Heart J 2002; 23:1329.</a></li><li><a class="nounderline abstract_t">Vink AS, Neumann B, Lieve KVV, et al. Determination and Interpretation of the QT Interval. Circulation 2018; 138:2345.</a></li><li><a class="nounderline abstract_t">Stramba-Badiale M, Karnad DR, Goulene KM, et al. For neonatal ECG screening there is no reason to relinquish old Bazett's correction. Eur Heart J 2018; 39:2888.</a></li><li><a class="nounderline abstract_t">Berul CI, Sweeten TL, Dubin AM, et al. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol 1994; 74:1254.</a></li><li><a class="nounderline abstract_t">Rautaharju PM, Zhang ZM, Prineas R, Heiss G. Assessment of prolonged QT and JT intervals in ventricular conduction defects. Am J Cardiol 2004; 93:1017.</a></li><li><a class="nounderline abstract_t">Malfatto G, Beria G, Sala S, et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 1994; 23:296.</a></li><li><a class="nounderline abstract_t">Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000; 102:2849.</a></li><li><a class="nounderline abstract_t">Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999; 34:823.</a></li><li><a class="nounderline abstract_t">Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107:838.</a></li><li><a class="nounderline abstract_t">Sy RW, van der Werf C, Chattha IS, et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011; 124:2187.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995; 92:3381.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89.</a></li><li><a class="nounderline abstract_t">Crotti L, Spazzolini C, Porretta AP, et al. Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol 2012; 60:2515.</a></li><li><a class="nounderline abstract_t">Horner JM, Horner MM, Ackerman MJ. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2011; 8:1698.</a></li><li><a class="nounderline abstract_t">Eggeling T, Hoeher M, Osterhues HH, et al. Significance of noninvasive diagnostic techniques in patients with long QT syndrome. Am J Cardiol 1992; 70:1421.</a></li><li><a class="nounderline abstract_t">Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87:1866.</a></li><li><a class="nounderline abstract_t">Eggeling T, Osterhues HH, Hoeher M, et al. Value of Holter monitoring in patients with the long QT syndrome. Cardiology 1992; 81:107.</a></li><li><a class="nounderline abstract_t">Lupoglazoff JM, Denjoy I, Berthet M, et al. Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations. Circulation 2001; 103:1095.</a></li><li><a class="nounderline abstract_t">Mauriello DA, Johnson JN, Ackerman MJ. Holter monitoring in the evaluation of congenital long QT syndrome. Pacing Clin Electrophysiol 2011; 34:1100.</a></li><li><a class="nounderline abstract_t">Etienne P, Huchet F, Gaborit N, et al. Mental stress test: a rapid, simple, and efficient test to unmask long QT syndrome. Europace 2018; 20:2014.</a></li><li><a class="nounderline abstract_t">Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013; 10:1932.</a></li><li><a class="nounderline abstract_t">Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8:1308.</a></li><li><a class="nounderline abstract_t">Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2018; 138:e272.</a></li><li><a class="nounderline abstract_t">Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99:518.</a></li><li><a class="nounderline abstract_t">Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 1999; 99:674.</a></li><li><a class="nounderline abstract_t">Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102:1178.</a></li><li><a class="nounderline abstract_t">Taggart NW, Haglund CM, Ackerman MJ. Diagnostic miscues in congenital long QT syndrome. Heart Rhythm 2006; 3:S67.</a></li><li><a class="nounderline abstract_t">Gaba P, Bos JM, Cannon BC, et al. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome. Heart Rhythm 2016; 13:879.</a></li><li><a class="nounderline abstract_t">Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985; 109:399.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88:782.</a></li><li><a class="nounderline abstract_t">Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 2006; 259:39.</a></li><li><a class="nounderline abstract_t">Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011; 124:2181.</a></li></ol></div><div id="topicVersionRevision">Topic 1053 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23509228" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14999113" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Drug-induced prolongation of the QT interval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11812408" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical and therapeutic aspects of congenital and acquired long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12484714" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Novel insights in the congenital long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10924312" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Congenital and acquired long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10898405" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The long QT syndromes: genetic basis and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23684683" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Impact of genetics on the clinical management of channelopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8256750" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Rate-corrected QT interval: techniques and limitations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11332559" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Problems of heart rate correction in assessment of drug-induced QT interval prolongation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16882679" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Electrocardiographic risk stratification in families with congenital long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17502575" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diagnostic miscues in congenital long-QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3337022" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Importance of lead selection in QT interval measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3337022" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Importance of lead selection in QT interval measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14954534" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The measurement of the Q-T interval of the electrocardiogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12709470" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : What clinicians should know about the QT interval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11847147" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : More light on QT interval measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598974" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : "Optimum" formulae for heart rate correction of the QT interval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : An analysis of the time-relations of electrocardiograms</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12269267" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Guidelines for the interpretation of the neonatal electrocardiogram. A task force of the European Society of Cardiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30571576" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Determination and Interpretation of the QT Interval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29860404" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : For neonatal ECG screening there is no reason to relinquish old Bazett's correction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977100" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15081446" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Assessment of prolonged QT and JT intervals in ventricular conduction defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7905012" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11104743" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10483966" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12591753" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22042885" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8521555" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136691" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23158531" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699858" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1442612" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Significance of noninvasive diagnostic techniques in patients with long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8099317" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The long QT syndrome in children. An international study of 287 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1286468" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Value of Holter monitoring in patients with the long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11222472" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21507020" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Holter monitoring in the evaluation of congenital long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29688407" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Mental stress test: a rapid, simple, and efficient test to unmask long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011539" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21787999" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29084731" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9927398" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9950666" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10973849" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Diagnostic miscues in congenital long QT syndrome</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26681611" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966369" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Idiopathic long QT syndrome: progress and questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8339437" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnostic criteria for the long QT syndrome. An update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16336512" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The congenital long QT syndromes from genotype to phenotype: clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22083145" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : QTc behavior during exercise and genetic testing for the long-QT syndrome.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
